Cite
MLA Citation
Andrea Alemany et al.. “Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial.” EClinicalMedicine, vol. 57, 2023, p. . http://access.bl.uk/ark:/81055/vdc_100185069615.0x000002